The US Institute of Medicine (IoM) has recently released a report supporting the movement for full transparency in clinical trial information saying, “releasing information is in the public interest and maximizes the contributions made by clinical trial participants...
The European Union (EU) recently published over 70 pages of legislation to conclude the long, exhaustive effort to remedy their old system of clinical trial regulations. Daniel Cressey’s article on nature.com highlights important takeaways from the legislation as well...
An article posted on clindev.eu shares that the European Medicines Agency (EMA) has announced a three month public consultation of a draft transparency policy regarding clinical trial information. EMA is hoping to launch the policy in early 2014. Potential threats to...
FierceBiotechIT.com journalist Ryan Mcbride shares that an alliance with close to 70 organizations has been formed to improve how genomic and clinical data are managed and shared. This alliance is a response to how ineffective big data sharing has been for people...
The discussion between professionals of how to rebuild public trust regarding clinical trials may stem from the worldwide concern in the biomedical research community about the low capture rate of trials reported as reported on redOrbit.com. One theory to help raise...